Fourteen of these 16 genes are in pathways affecting immunity or inflammation, and six—CD5, CTLA4, TIGIT, LAIR1, TNFRSF14, and PDCD1—encode receptors that have been characterized as immune checkpoints exploited by cancer cells to escape the immune response. This evidence concerns the gene CTLA4 and cancer.